Senate Bill 2535
115th Congress(2017-2018)
Opioid Quota Reform Act
Introduced
Introduced in Senate on Mar 12, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2535
Congress
115
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
No Senate votes have been held for this bill.
Summary
Opioid Quota Reform Act
This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to consider additional factors—the impact on overall public health and rates of diversion, abuse, and overdose deaths—in setting and adjusting production and manufacturing quotas for fentanyl, oxycodone, hydrocodone, oxymorphone, and hydromorphone.
Additionally, if the DEA increases the production quota of fentanyl, oxycodone, hydrocodone, oxymorphone, or hydromorphone, then it must explain why the public health benefits of increasing the quota outweigh the consequences of potential diversion.
06/19/2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 473.
06/19/2018
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
05/24/2018
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
03/12/2018
Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S1632)
03/12/2018
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:40:00 PM